Literature DB >> 33800371

Trajectories of Depressive Symptoms and Anxiety during Pregnancy and Associations with Pregnancy Stress.

Hyejung Lee1, Ki-Eun Kim2, Mi-Young Kim3, Chang Gi Park4, Jung Yeol Han5, Eun Jeong Choi5.   

Abstract

The purposes of this study were to investigate the trajectory groups of depressive symptoms and anxiety in women during pregnancy and to identify the factors associated with those groups. Participants were recruited from the outpatient clinic of a women's health hospital in Seoul, Korea. Pregnant women (n = 136) completed a survey questionnaire that included questions on depressive symptoms, anxiety, and pregnancy stress; additionally, their saliva was tested for cortisol hormone levels three times during their pregnancies. The group-based trajectory modeling approach was used to identify latent trajectory groups. Ordinal logistic regressions were used to explore the association of latent trajectory groups with sociodemographic factors and pregnancy stress. Three trajectory groups of depressive symptoms were identified: low-stable (70%), moderate-stable (25%), and increased (5%). Four trajectory groups of anxiety were identified: very low-stable (10%), low-stable (67%), moderate-stable (18%), and high-stable (5%). The only factor associated with both the depressive symptoms and anxiety trajectory groups was pregnancy stress (p < 0.001). Most participants showed stable emotional status; however, some participants experienced higher levels of depressive symptoms and anxiety related to higher pregnancy stress. These pregnant women may need additional care from healthcare providers to promote their wellbeing during pregnancy.

Entities:  

Keywords:  Korea; anxiety; cortisol; depression; pregnancy; trajectory analysis

Year:  2021        PMID: 33800371      PMCID: PMC7967460          DOI: 10.3390/ijerph18052733

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  34 in total

Review 1.  Heterogeneity in perinatal depression: how far have we come? A systematic review.

Authors:  Hudson Santos; Xianming Tan; Rebecca Salomon
Journal:  Arch Womens Ment Health       Date:  2016-10-29       Impact factor: 3.633

Review 2.  Depression During Pregnancy and Postpartum.

Authors:  Madeleine Becker; Tal Weinberger; Ann Chandy; Sarah Schmukler
Journal:  Curr Psychiatry Rep       Date:  2016-03       Impact factor: 5.285

3.  Acculturative stress is associated with trajectory of anxiety symptoms during pregnancy in Mexican-American women.

Authors:  Andrea Preciado; Kimberly D'Anna-Hernandez
Journal:  J Anxiety Disord       Date:  2016-10-07

4.  Relationship between Maternal General and Specific-Pregnancy Stress, Anxiety, and Depression Symptoms and Pregnancy Outcome.

Authors:  Parvin Hasanjanzadeh; Mahbobeh Faramarzi
Journal:  J Clin Diagn Res       Date:  2017-04-01

5.  Associations between maternal psychological distress and salivary cortisol during pregnancy: A mixed-models approach.

Authors:  Marion I van den Heuvel; Marcel A L M van Assen; Vivette Glover; Stephan Claes; Bea R H Van den Bergh
Journal:  Psychoneuroendocrinology       Date:  2018-06-05       Impact factor: 4.905

6.  Effects of an early intervention on perceived stress and diurnal cortisol in pregnant women with elevated stress, anxiety, and depressive symptomatology.

Authors:  Judith Richter; Antje Bittner; Katja Petrowski; Juliane Junge-Hoffmeister; Sybille Bergmann; Peter Joraschky; Kerstin Weidner
Journal:  J Psychosom Obstet Gynaecol       Date:  2012-10-19       Impact factor: 2.949

7.  Trajectories of stress biomarkers and anxious-depressive symptoms from pregnancy to postpartum period in women with a trauma history.

Authors:  Farah Ghosn; Belén Almansa; Alba Moreno-Giménez; Rosa Sahuquillo-Leal; Elena Serrano-Lozano; David Hervás; Vicente Diago; Consuelo Cháfer-Pericás; Máximo Vento; Ana García Blanco
Journal:  Eur J Psychotraumatol       Date:  2019-04-29

8.  Seasonal variation in salivary cortisol but not symptoms of depression and trait anxiety in pregnant women undergoing an elective caesarean section.

Authors:  Samantha M Garay; Katrina A Savory; Lorna A Sumption; Richard J A Penketh; Ian R Jones; Anna B Janssen; Rosalind M John
Journal:  Psychoneuroendocrinology       Date:  2019-05-31       Impact factor: 4.905

9.  Anxiety in pregnancy: prevalence and associated factors.

Authors:  Mônica Maria de Jesus Silva; Denismar Alves Nogueira; Maria José Clapis; Eliana Peres Rocha Carvalho Leite
Journal:  Rev Esc Enferm USP       Date:  2017-08-28       Impact factor: 1.086

Review 10.  Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile.

Authors:  Brenda W J H Penninx; Yuri Milaneschi; Femke Lamers; Nicole Vogelzangs
Journal:  BMC Med       Date:  2013-05-15       Impact factor: 8.775

View more
  4 in total

1.  Prevalence of Depression during Pregnancy in Spanish Women: Trajectory and Risk Factors in Each Trimester.

Authors:  M Carmen Míguez; M Belén Vázquez
Journal:  Int J Environ Res Public Health       Date:  2021-06-24       Impact factor: 3.390

2.  Effect of individual or comorbid antenatal depression and anxiety on birth outcomes and moderation by maternal traumatic experiences and resilience.

Authors:  Arielle R Deutsch; Minga C Vargas; Maristella Lucchini; Lucy T Brink; Hein J Odendaal; Amy J Elliott
Journal:  J Affect Disord Rep       Date:  2022-05-19

3.  Maternal mental health and breastfeeding amidst the Covid-19 pandemic: cross-sectional study in Catalonia (Spain).

Authors:  Marta Nicolás-López; Pablo González-Álvarez; Anna Sala de la Concepción; Paula Sol Ventura Wichner; Gemma Ginovart; Maria Giralt-López; Beatriz Lorente; Inés Velasco
Journal:  BMC Pregnancy Childbirth       Date:  2022-09-26       Impact factor: 3.105

4.  Validity and Reliability of the Caregiver Strain Index Scale in Women during the Puerperium in Spain.

Authors:  David Feligreras-Alcalá; María Del Pilar Cazalilla-López; Rafael Del-Pino-Casado; Antonio Frías-Osuna
Journal:  Int J Environ Res Public Health       Date:  2021-03-30       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.